Suppression of spleen lymphocyte mitogenesis in mice injected with platinum compounds.
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D002945:Cisplatin / Q000494:pharmacology*; D003208:Concanavalin A / Q000494:pharmacology; D003514:Cyclohexylamines / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D007958:Leukocyte Count; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D051379:Mice; D009944:Organoplatinum Compounds / Q000494:pharmacology*; D010655:Phenylenediamines / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D003514:Cyclohexylamines; D003517:Cyclopentanes; D008070:Lipopolysaccharides; D009944:Organoplatinum Compounds; D010655:Phenylenediamines; D003208:Concanavalin A; D002945:Cisplatin